Folate network genetic variation predicts cardiovascular disease risk in non-Hispanic white males.

Genes functioning in folate-mediated 1-carbon metabolism are hypothesized to play a role in cardiovascular disease (CVD) risk beyond the current narrow focus on the MTHFR 677 C→T (rs1801133) polymorphism. Using a cohort study design, we investigated whether sequence variants in the network of folate-related genes, particularly in genes encoding proteins related to SHMT1, predict CVD risk in 1131 men from the Normative Aging Study. A total of 330 single nucleotide polymorphisms (SNPs) in 52 genes, selected for function and gene coverage, were assayed on the Illumina GoldenGate platform. Age- and smoking-adjusted genotype-phenotype associations were estimated in regression models. Using a nominal P ≤ 5.00 × 10(-3) significance threshold, 8 SNPs were associated with CVD risk in single locus analyses. Using a false discovery rate (FDR) threshold (P-adjusted ≤1.00 × 10(-1)), a SNP in the GGH gene remained associated with reduced CVD risk, with a stronger association in early onset CVD cases (<55 y). A gene × folate interaction (MAT2B) and 2 gene × vitamin B-12 interactions (BHMT, SLC25A32) reached the FDR P-adjusted ≤2.00 × 10(-1) threshold. Three biological hypotheses related to SHMT1 were explored and significant gene × gene interactions were identified for TYMS by UBE2N, FTH1 by CELF1, and TYMS by MTHFR. Variations in genes other than MTHFR and those directly involved in homocysteine metabolism are associated with CVD risk in non-Hispanic white males. This work supports a role for SHMT1-related genes and nuclear folate metabolism, including the thymidylate biosynthesis pathway, in mediating CVD risk.

[1]  P. Stover,et al.  Mthfs is an Essential Gene in Mice and a Component of the Purinosome , 2011, Front. Gene..

[2]  P. Stover,et al.  Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. , 2011, The American journal of clinical nutrition.

[3]  M. Mcentee,et al.  Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk. , 2011, Cancer research.

[4]  E. Rimm,et al.  Polymorphisms in serine hydroxymethyltransferase 1 and methylenetetrahydrofolate reductase interact to increase cardiovascular disease risk in humans. , 2011, The Journal of nutrition.

[5]  L. Appel,et al.  Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. , 2010, The American journal of cardiology.

[6]  I. Rosenberg,et al.  MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate. , 2010, The American journal of clinical nutrition.

[7]  Martin T. Wells,et al.  Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study , 2010, BMC Medical Genetics.

[8]  P. Vokonas,et al.  Candidate genes for respiratory disease associated with markers of inflammation and endothelial dysfunction in elderly men. , 2009, Atherosclerosis.

[9]  P. Vokonas,et al.  A Prospective Study of Bone Lead Concentration and Death From All Causes, Cardiovascular Diseases, and Cancer in the Department of Veterans Affairs Normative Aging Study , 2009, Circulation.

[10]  P. Stover,et al.  SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis , 2009, PloS one.

[11]  R. Collins,et al.  Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women’s Genome Health Study , 2009, Circulation. Cardiovascular genetics.

[12]  P. Stover,et al.  5,10-Methenyltetrahydrofolate synthetase activity is increased in tumors and modifies the efficacy of antipurine LY309887. , 2009, Archives of biochemistry and biophysics.

[13]  J. Mason,et al.  Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. , 2008, The American journal of clinical nutrition.

[14]  Stephen J Benkovic,et al.  Reversible Compartmentalization of de Novo Purine Biosynthetic Complexes in Living Cells , 2008, Science.

[15]  P. Vokonas,et al.  Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease , 2008, Circulation.

[16]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[17]  P. Stover,et al.  A Ferritin-responsive Internal Ribosome Entry Site Regulates Folate Metabolism* , 2007, Journal of Biological Chemistry.

[18]  R. Jain,et al.  Trends in blood folate and vitamin B-12 concentrations in the United States, 1988 2004. , 2007, The American journal of clinical nutrition.

[19]  P. Stover,et al.  Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway* , 2007, Journal of Biological Chemistry.

[20]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[21]  J. Selhub,et al.  The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. , 2006, The Journal of nutrition.

[22]  P. Stover,et al.  Regulation of de Novo Purine Biosynthesis by Methenyltetrahydrofolate Synthetase in Neuroblastoma* , 2006, Journal of Biological Chemistry.

[23]  S. Lewis,et al.  Meta-analysis of MTHFR 677C→ T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? , 2005, BMJ : British Medical Journal.

[24]  M. Landray,et al.  Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. , 2005, The American journal of clinical nutrition.

[25]  R. Strawderman,et al.  Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. , 2005, The Journal of nutrition.

[26]  K. Furie,et al.  Dose-Related Association of MTHFR 677T Allele With Risk of Ischemic Stroke: Evidence From a Cumulative Meta-Analysis , 2005, Stroke.

[27]  A. Hingorani,et al.  Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. , 2004, Archives of neurology.

[28]  P. Vokonas,et al.  Are Varicose Veins a Marker for Susceptibility to Coronary Heart Disease in Men? Results from the Normative Aging Study , 2004, Annals of vascular surgery.

[29]  P. Ueland,et al.  Betaine as a Determinant of Postmethionine Load Total Plasma Homocysteine Before and After B-Vitamin Supplementation , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[30]  J. Galivan,et al.  Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms. , 2003, Gene.

[31]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.

[32]  Petra Verhoef,et al.  MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis. , 2002, JAMA.

[33]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[34]  Katherine L. Herbig,et al.  Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.

[35]  P. Vokonas,et al.  Depression and the risk of coronary heart disease in the Normative Aging Study. , 1998, The American journal of cardiology.

[36]  T. Garrow.  Purification, Kinetic Properties, and cDNA Cloning of Mammalian Betaine-Homocysteine Methyltransferase* , 1996, The Journal of Biological Chemistry.

[37]  A. Maekawa,et al.  Effect of vitamin B12-deficiency on the activity of hepatic cystathionine beta-synthase in rats. , 1989, Journal of nutritional science and vitaminology.

[38]  B. Bell,et al.  The Veterans Administration longitudinal study of healthy aging. , 1966, The Gerontologist.

[39]  Georgia Salanti,et al.  Homocysteine lowering interventions for preventing cardiovascular events. , 2009, The Cochrane database of systematic reviews.

[40]  P. Stover,et al.  Folate-mediated one-carbon metabolism. , 2008, Vitamins and hormones.

[41]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[42]  P. Stover,et al.  Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase , 2007, Clinical chemistry and laboratory medicine.

[43]  Ning Qiao,et al.  High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. , 2005, The American journal of clinical nutrition.

[44]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[45]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[46]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .